Redesigned protein opens door for safer gene therapy
Wednesday, November 13, 2013 - 14:30
in Biology & Nature
A fusion protein combining proteins active in HIV and Moloney murine leukaemia virus (MLV) replication may lead to safer, more effective retroviral gene therapy.